DKS Co (4461) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Oct, 2026Executive summary
Six-month net sales rose 21.3% YoY to ¥35,431 million, with all segments contributing to growth, especially Functional Materials.
Operating income reached ¥2,474 million, reversing a ¥449 million loss; profit attributable to owners of parent was ¥1,256 million, versus a ¥478 million loss.
Comprehensive income increased 178.1% YoY to ¥2,456 million.
Financial highlights
Gross profit rose to ¥8,724 million from ¥5,156 million; ordinary income was ¥2,579 million, versus a ¥379 million loss.
Basic EPS improved to ¥131.25 from a loss of ¥50.03; net assets per share increased to ¥3,954.51 from ¥3,839.89 at March 31, 2024.
Total assets were ¥92,956 million, down ¥1,581 million from March 31, 2024; the equity ratio improved to 40.7% from 38.9%.
Outlook and guidance
Full-year forecast maintained: net sales ¥73,000 million, operating income ¥5,000 million, parent-attributable profit ¥2,500 million, and EPS ¥261.11.
FY2025 dividend forecast unchanged at ¥90 per share.
Latest events from DKS Co
- Record sales and profits driven by high-value products and upwardly revised guidance.4461
Q1 2027 - Aims for ¥100B sales and 10% margin by 2030 through innovation, ESG, and global expansion.4461
Corporate presentation - Q1 growth and profit recovery were led by electronics, battery and Functional Materials.4461
Q1 2025 - Strong sales and profit growth driven by electronics and Functional Materials.4461
Q3 2025 - Record-high earnings driven by electronics and battery materials, with further growth forecast.4461
Q4 2025 - Record Q1 profit and sales growth, with upward guidance, led by electronics and battery materials.4461
Q1 2026 - Record profits and strong sales in key segments drive upward revision of outlook and dividend.4461
Q2 2026 - Record sales and profits, with FY2025 guidance and dividends raised above plan targets.4461
Q3 2026 - Record sales and profits driven by high-value products, with continued growth forecasted.4461
Q4 2026